Metolazone

美托拉宗

Report date: 2025/06/06 20:01:13
NME

Base Information

Drug NameMetolazone
Drug Alias Name甲苯喹唑磺胺metolazonaMetolazonum甲苯喹唑酮美托拉亲 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporter
Therapy Area/IndicationsEdemaHypertensionHeart Failure +[6] 
Global Approved IndicationsEdemaHypertensionHeart Failure
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1973/11/27
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaPending
Originator CompaniesUcb
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMylan Pharmaceuticals IncStanford UniversityChartwell Molecular Holdings Llc +[6] 
Active IndicationsN/A
Inactive IndicationsEdemaHypertensionHeart Failure +[6] 

Other Information

ATC CodeC03BA08
Related LinksWikipediaDrugBankKEGG